| Bioactivity | Zurletrectinib is a potent tyrosine kinase inhibitor. Zurletrectinib serves as an antineoplastic agent. Zurletrectinib can used for research of preventing TRK-mediated related diseases, such as tumors[1][2]. |
| Name | Zurletrectinib |
| CAS | 2403703-30-8 |
| Formula | C19H19F2N7O2 |
| Molar Mass | 415.40 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Kong NX, et al. Preparation of the heterocyclic compounds as trk inhibitor: World Intellectual Property Organization, WO2020001415. 2020-01-02. [2]. WHO Drug Information-World Health Organization (WHO). |
Zurletrectinib
CAS: 2403703-30-8 F: C19H19F2N7O2 W: 415.40
Zurletrectinib is a potent tyrosine kinase inhibitor. Zurletrectinib serves as an antineoplastic agent. Zurletrectinib c
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.